Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study.

A double-blind, placebo-controlled study of mefloquine antimalarial prophylaxis in pregnancy (> 20 weeks of gestation) was conducted in 339 Karen women living in an area of multidrug-resistant malaria transmission on the Thai-Burmese border. Mefloquine gave > or = 86% (95% confidence interval [CI], 59%-94%) protection against Plasmodium falciparum and complete protection against Plasmodium vivax infections. Mefloquine prophylaxis was well tolerated; use of an initial loading dose (10 mg/kg) was associated with transient dizziness, but there were no other significant adverse effects on the mother, the pregnancy, or infant survival or development (followed for 2 years). Falciparum malaria was associated with maternal anemia and a mean reduction in birth weight in gravidae I, II, and III of 225 g (95% CI, 26-423). Maternal anemia at delivery (hematocrit < 30%) was associated with increased infant mortality: 26% versus 15% (relative risk, 1.9; 95% CI, 1.1-3.2). Mefloquine is safe and effective for antimalarial prophylaxis in the second half of pregnancy.

[1]  P. Phillips-Howard,et al.  Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa , 1993, The Lancet.

[2]  H. Lobel,et al.  Long-term malaria prophylaxis with weekly mefloquine , 1993, The Lancet.

[3]  R. Steketee,et al.  Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. , 1993, The Journal of infectious diseases.

[4]  H. Webster,et al.  High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria. , 1992, The Journal of infectious diseases.

[5]  N. White,et al.  Antimalarial drug resistance: the pace quickens. , 1992, The Journal of antimicrobial chemotherapy.

[6]  R. Snow,et al.  Malaria chemoprophylaxis, birth weight and child survival. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  L. Kerr,et al.  Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions. , 1992, The Journal of tropical medicine and hygiene.

[8]  H. Webster,et al.  Mefloquine-resistant falciparum malaria on the Thai-Burmese border , 1991, The Lancet.

[9]  N. White,et al.  Clinical Pharmacokinetics of Mefloquine , 1990, Clinical pharmacokinetics.

[10]  N. White,et al.  Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study. , 1990, British journal of clinical pharmacology.

[11]  B. Brabin,et al.  Consequences of maternal anaemia on outcome of pregnancy in a malaria endemic area in Papua New Guinea. , 1990, Annals of tropical medicine and parasitology.

[12]  R. Snow,et al.  The effects of malaria chemoprophylaxis given by traditional birth attendants on the course and outcome of pregnancy. , 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[13]  M. Ounsted.  Gestational age of the newborn , 1978 .

[14]  H. Gilles,et al.  Malaria, anaemia and pregnancy. , 1969, Annals of tropical medicine and parasitology.

[15]  N. White,et al.  The pathophysiology of malaria. , 1992, Advances in parasitology.

[16]  J. Verhave,et al.  Effect of chloroquine chemoprophylaxis during pregnancy on birth weight: results of a randomized trial. , 1992, The American journal of tropical medicine and hygiene.

[17]  J. Roosmalen.  Birth weights in two rural hospitals in the United Republic of Tanzania. , 1988 .

[18]  A. Fleming,et al.  The prevention of anaemia in pregnancy in primigravidae in the guinea savanna of Nigeria. , 1986, Annals of tropical medicine and parasitology.

[19]  M. E. Wilson,et al.  Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weight. , 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[20]  B. Brabin.  An analysis of malaria in pregnancy in Africa. , 1983, Bulletin of the World Health Organization.